Check out your Company Bowl for anonymous work chats.
Adaptive Biotechnologies Appoints Tycho Peterson as Chief Financial Officer, Reorganizes and Streamlines Workforce to Drive Growth in Two Key Business Areas
Molecular Laboratory Operations: The Heartbeat of Adaptive
In honor of World Cancer Day, we sat down with two Adapters to understand how their personal experiences with cancer intersect with their work at Adaptive. Kathy Thompson (Key Account Manager, clonoSEQ sales) is a stage 1 colorectal cancer survivor. Shannon Fatigante (Talent Acquisition Senior Program Manager) has a father currently fighting chronic lymphocytic leukemia (CLL).
It's more than a number: Pride co-leader Shay Miller on the impact of Adaptive’s high marks on the HRC Corporate Equality Index
CEO, Chad Robins, stopped by Bloomberg News to discuss the important role T cells play in the immune system’s response to SARS-CoV-2.
T cells step into the limelight in the face of variants. Chief Scientific Officer, Harlan Robins, makes the case for including T cell response into large COVID-19 vaccine trials going forward.
We’re proud to be named one of Fast Company’s Next Big Things in Tech!
Remaining Vigilant Against COVID-19 and Future Pandemics Means Opening Our Eyes to the T-Cell Immune Response
A Conversation with Jenny Ahlstrom of Myeloma Crowd about Multiple Myeloma, MRD and the Changing Treatment Landscape
Adaptive Biotechnologies Presents New Data During IDWeek Demonstrating the Capability of Its Immune Medicine Platform to Distinguish Between SARS-CoV-2 Infection and Vaccine Response and Detect Lyme Disease
